Lupron Depot leuprolide regulatory update

FDA accepted for filing an sNDA from Abbott for a 6-month, 45 mg formulation of Lupron Depot leuprolide for the palliative treatment of advanced prostate cancer. The PDUFA date is undisclosed. The gon...